Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 810563, 9 pages
http://dx.doi.org/10.1155/2012/810563
Research Article

Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways

1Laboratory of Translational Therapeutics, Pharmacology Research Center, Bio-Organic Science Division, Korea Research Institute of Chemical Technology, P.O. Box 107, Yuseong-gu, Daejeon 305-600, Republic of Korea
2Department of Pharmacy, Sunchon National University, Suncheon 540-742, Republic of Korea
3Department of Food and Nutrition, Kwangju Women's University, Gwangju 506-713, Republic of Korea

Received 11 July 2012; Accepted 9 August 2012

Academic Editor: Ima Nirwana Soelaiman

Copyright © 2012 Sik-Won Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Sik-Won Choi, Young-Jin Son, Jung-Mi Yun, and Seong Hwan Kim, “Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 810563, 9 pages, 2012. https://doi.org/10.1155/2012/810563.